Abacavir-induced liver toxicity
Autor(a) principal: | |
---|---|
Data de Publicação: | 2016 |
Outros Autores: | , , , |
Tipo de documento: | Relatório |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Infectious Diseases |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702016000500502 |
Resumo: | Abstract Abacavir-induced liver toxicity is a rare event almost exclusively occurring in HLA B*5701-positive patients. Herein, we report one case of abnormal liver function tests occurring in a young HLA B*5701-negative woman on a stable nevirapine-based regimen with no history of liver problems or alcohol abuse after switching to abacavir from tenofovir. We also investigated the reasons for abacavir discontinuation in a cohort of patients treated with abacavir-lamivudine-nevirapine. |
id |
BSID-1_64937d51fb7975622950730cd52109b3 |
---|---|
oai_identifier_str |
oai:scielo:S1413-86702016000500502 |
network_acronym_str |
BSID-1 |
network_name_str |
Brazilian Journal of Infectious Diseases |
repository_id_str |
|
spelling |
Abacavir-induced liver toxicityHIVAbacavirLiver toxicityAbstract Abacavir-induced liver toxicity is a rare event almost exclusively occurring in HLA B*5701-positive patients. Herein, we report one case of abnormal liver function tests occurring in a young HLA B*5701-negative woman on a stable nevirapine-based regimen with no history of liver problems or alcohol abuse after switching to abacavir from tenofovir. We also investigated the reasons for abacavir discontinuation in a cohort of patients treated with abacavir-lamivudine-nevirapine.Brazilian Society of Infectious Diseases2016-10-01info:eu-repo/semantics/reportinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702016000500502Brazilian Journal of Infectious Diseases v.20 n.5 2016reponame:Brazilian Journal of Infectious Diseasesinstname:Brazilian Society of Infectious Diseases (BSID)instacron:BSID10.1016/j.bjid.2016.03.002info:eu-repo/semantics/openAccessPezzani,Maria DilettaResnati,ChiaraDi Cristo,ValentinaRiva,AgostinoGervasoni,Cristinaeng2016-10-26T00:00:00Zoai:scielo:S1413-86702016000500502Revistahttps://www.bjid.org.br/https://old.scielo.br/oai/scielo-oai.phpbjid@bjid.org.br||lgoldani@ufrgs.br1678-43911413-8670opendoar:2016-10-26T00:00Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)false |
dc.title.none.fl_str_mv |
Abacavir-induced liver toxicity |
title |
Abacavir-induced liver toxicity |
spellingShingle |
Abacavir-induced liver toxicity Pezzani,Maria Diletta HIV Abacavir Liver toxicity |
title_short |
Abacavir-induced liver toxicity |
title_full |
Abacavir-induced liver toxicity |
title_fullStr |
Abacavir-induced liver toxicity |
title_full_unstemmed |
Abacavir-induced liver toxicity |
title_sort |
Abacavir-induced liver toxicity |
author |
Pezzani,Maria Diletta |
author_facet |
Pezzani,Maria Diletta Resnati,Chiara Di Cristo,Valentina Riva,Agostino Gervasoni,Cristina |
author_role |
author |
author2 |
Resnati,Chiara Di Cristo,Valentina Riva,Agostino Gervasoni,Cristina |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Pezzani,Maria Diletta Resnati,Chiara Di Cristo,Valentina Riva,Agostino Gervasoni,Cristina |
dc.subject.por.fl_str_mv |
HIV Abacavir Liver toxicity |
topic |
HIV Abacavir Liver toxicity |
description |
Abstract Abacavir-induced liver toxicity is a rare event almost exclusively occurring in HLA B*5701-positive patients. Herein, we report one case of abnormal liver function tests occurring in a young HLA B*5701-negative woman on a stable nevirapine-based regimen with no history of liver problems or alcohol abuse after switching to abacavir from tenofovir. We also investigated the reasons for abacavir discontinuation in a cohort of patients treated with abacavir-lamivudine-nevirapine. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-10-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/report |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
report |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702016000500502 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702016000500502 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1016/j.bjid.2016.03.002 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Brazilian Society of Infectious Diseases |
publisher.none.fl_str_mv |
Brazilian Society of Infectious Diseases |
dc.source.none.fl_str_mv |
Brazilian Journal of Infectious Diseases v.20 n.5 2016 reponame:Brazilian Journal of Infectious Diseases instname:Brazilian Society of Infectious Diseases (BSID) instacron:BSID |
instname_str |
Brazilian Society of Infectious Diseases (BSID) |
instacron_str |
BSID |
institution |
BSID |
reponame_str |
Brazilian Journal of Infectious Diseases |
collection |
Brazilian Journal of Infectious Diseases |
repository.name.fl_str_mv |
Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID) |
repository.mail.fl_str_mv |
bjid@bjid.org.br||lgoldani@ufrgs.br |
_version_ |
1754209243792146432 |